Bulgaria's Sopharma gets regulatory nod to merge Biopharm Engineering
The Bulgarian financial regulator said it has authorised local pharmaceuticals maker Sopharma [BUL:SFA] to absorb majority-owned subsidiary Biopharm Engine
Source: seenews.com
Stay updated with breaking news from Biopharm Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Bulgarian financial regulator said it has authorised local pharmaceuticals maker Sopharma [BUL:SFA] to absorb majority-owned subsidiary Biopharm Engine
Bulgarian pharmaceuticals producer Sopharma [BUL:SFA] said on Friday that it has sought consent from the financial regulator to absorb its majority-owned l
Bulgarian pharmaceuticals producer Sopharma [BUL:SFA] said on Wednesday that it plans to absorb its local subsidiary Biopharm Engineering, which it control